Uncontrolled IL-17 production by intraepithelial lymphocytes in a case of non-IPEX autoimmune enteropathy

Clinical and Translational Gastroenterology

Volumn 7, Issue 7, 2016, Pages

  Paroni, Moira ^a   Magarotto, Andrea ^b   Tartari, Silvia ^a   Nizzoli, Giulia ^a   Larghi, Paola ^a,b   Ercoli, Giulia ^b,c   Gianelli, Umberto ^b,c   Pagani, Massimiliano ^a,b   Elli, Luca ^c   Abrignani, Sergio ^a,b   Conte, Dario ^b,c   Geginat, Jens ^a   Caprioli, Flavio ^b,c  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD103 ANTIGEN; ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 17; PREDNISONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DUODENUM BIOPSY; ENTEROPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOALBUMINEMIA; HYPOKALEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTESTINE ENDOSCOPY; INTESTINE VILLUS ATROPHY; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MALNUTRITION; NON IPEX AUTOIMMUNE ENTEROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; REGULATORY T LYMPHOCYTE; REMISSION; SMALL INTESTINE MUCOSA; STEROID THERAPY; THROMBOCYTOPENIA; UPREGULATION;

EID: 84988660327     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2016.41     Document Type: Article

References (50)

1. Gentile NM, Murray JA, Pardi DS. Autoimmune enteropathy: a review and update of clinical management. Curr Gastroenterol Rep 2012; 14: 380-385.
2. Akram S, Murray JA, Pardi DS et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol 2007; 5: 1282-1290 quiz 1245.
3. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012; 3: 211.
4. Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007; 38: 112-121.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
6. Moes N, Rieux-Laucat F, Begue B et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010; 139: 770-778.
7. Ruemmele FM, Brousse N, Goulet O. Autoimmune enteropathy: molecular concepts. Curr Opin Gastroenterol 2004; 20: 587-591.
8. Zuber J, Viguier M, Lemaitre F et al. Severe FOXP3+ and naive T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology 2007; 132: 1694-1704.
9. Bishu S, Arsenescu V, Lee EY et al. Autoimmune enteropathy with a CD8+ CD7- T-cell small bowel intraepithelial lymphocytosis: case report and literature review. BMC Gastroenterol 2011; 11: 131.
10. MacDonald TT, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988; 167: 1341-1349.
11. Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. Hum Pathol 2006; 37: 373-376.
12. Van Assche G, Dignass A, Panes J et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27.
13. Haringer B, Lozza L, Steckel B et al. Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med 2009; 206: 1009-1017.
14. Huber S, Gagliani N, Esplugues E et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011; 34: 554-565.
15. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-1861.
16. Ramesh R, Kozhaya L, McKevitt K et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 2014; 211: 89-104.
17. Ahern PP, Izcue A, Maloy KJ et al. The interleukin-23 axis in intestinal inflammation. Immunol Rev 2008; 226: 147-159.
18. Seiderer J, Brand S. IL-22: a two-headed cytokine in IBD? Inflamm Bowel Dis 2009; 15: 473-474.
19. Griseri T, McKenzie BS, Schiering C et al. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012; 37: 1116-1129.
20. Kastirr I, Maglie S, Paroni M et al. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells. J Immunol 2014; 193: 3322-3331.
21. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641-649.
22. Coccia M, Harrison OJ, Schiering C et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 2012; 209: 1595-1609.
23. Veldhoen M, Hocking RJ, Atkins CJ et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189.
24. Zanzi D, Stefanile R, Santagata S et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am J Gastroenterol 2011; 106: 1308-1317.
25. Tran DQ, Andersson J, Wang R et al. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009; 106: 13445-13450.
26. Fahlen L, Read S, Gorelik L et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 2005; 201: 737-746.
27. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435-446.
28. Nizzoli G, Krietsch J, Weick A et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 2013; 122: 932-942.
29. Asseman C, Mauze S, Leach MW et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
30. Maynard CL, Harrington LE, Janowski KM et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 2007; 8: 931-941.
31. Uhlig HH, Coombes J, Mottet C et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006; 177: 5852-5860.
32. Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742.
33. Glocker EO, Kotlarz D, Klein C et al. IL-10 and IL-10 receptor defects in humans. Ann NY Acad Sci 2011; 1246: 102-107.
34. Murch SH, Fertleman CR, Rodrigues C et al. Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: the contribution of T cells to the mucosal lesion. J Pediatr Gastroenterol Nutr 1999; 28: 393-399.
35. Hueber W, Sands BE, Lewitzky S et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012; 61: 1693-1700.
36. Huber S, Gagliani N, Flavell RA. Life, death, and miracles: Th17 cells in the intestine. Eur J Immunol 2012; 42: 2238-2245.
37. Cheroutre H. In IBD eight can come before four. Gastroenterology 2006; 131: 667-670.
38. Meresse B, Chen Z, Ciszewski C et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21: 357-366.
39. Hue S, Mention JJ, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21: 367-377.
40. Monteleone I, Sarra M, Del Vecchio Blanco G et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010; 184: 2211-2218.
41. Kumawat AK, Strid H, Tysk C et al. Microscopic colitis patients demonstrate a mixed Th17/ Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol 2013; 55: 355-364.
42. Park SG, Mathur R, Long M et al. T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T cells. Immunity 2010; 33: 791-803.
43. Geginat J, Paroni M, Maglie S et al. Plasticity of human CD4 T cell subsets. Front Immunol 2014; 5: 630.
44. Persson EK, Uronen-Hansson H, Semmrich M et al. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013; 38: 958-969.
45. Santarlasci V, Maggi L, Capone M et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 2009; 39: 207-215.
46. Cosmi L, De Palma R, Santarlasci V et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205: 1903-1916.
47. Mercer F, Khaitan A, Kozhaya L et al. Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J Immunol 2014; 193: 1047-1054.
48. Kastirr I, Crosti M, Maglie S et al. Signal Strength and Metabolic Requirements Control Cytokine-Induced Th17 Differentiation of Uncommitted Human T Cells. J Immunol 2015; 195: 3617-3627.
49. Torchinsky MB, Garaude J, Martin AP et al. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009; 458: 78-82.
50. Monteleone G, Neurath MF, Ardizzone S et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med 2015; 372: 1104-1113.